Pasar al contenido principal

DESARROLLO DE PROCESOS FOTONDUCIDOS Y COMPUESTOS FOTOACTIVABLES COMO INTERPRETES CELULARES

PID2023-146801NB-C32

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Photocatalyst-free light-mediated three-component alkoxy-, hydroxy-, and azidotrifluoromethylation of alkenes

  • Ji, Yingmin|||0009-0002-0044-5520
  • Jaafar, Aida|||0000-0001-6420-1897
  • Gimbert-Suriñach, Carolina|||0000-0002-4412-7607
  • Ribagorda, María|||0000-0001-7185-4095
  • Vallribera, Adelina|||0000-0002-6452-4589
  • Granados, Albert|||0000-0002-5362-5966
  • Cabrera-Afonso, María Jesús|||0000-0002-3736-3206
Photoinduced radical-polar crossover (RPC) reactions generally rely on the use of an external photocatalyst to generate the corresponding radical and ionic species, selected according to the redox potentials of the involved species. Herein, we describe a multicomponent light-induced RPC reaction that does not require an exogenous photocatalyst, enabling the efficient synthesis of diverse 1,2-trifluoromethyl alkyl ethers, alcohols, and azides. This protocol allows for the bifunctionalization of alkenes under mild conditions using purple light and a thianthrenium salt as a trifluoromethylating agent. Mechanistic experiments confirmed the formation of a benzylic sulfonium intermediate that can participate in different nucleophilic substitution reactions, being an alternative photocatalyst-free method to the classical RPC.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expanding the chemical space for antiviral discovery: the potential of twistenediones

  • Jaafar, Aida
  • Guerra-González, Daniel
  • Pascual, Ana
  • Ortuño, Ana M.
  • Cruz, Carlos M.
  • Cuerva, Juan M.
  • Bueno, Paula
  • Castro, Victoria
  • Garaigorta, Urtzi
  • Gastaminza, Pablo
  • Adrio, Javier
  • Ribagorda, María
Despite significant progress in drug discovery, there remains an urgent need to identify new structures capable of targeting drug-resistant diseases, as well as novel pathogens, to address the growing challenges in global health. This work highlights the underexplored potential of twistane-like structures as promising candidates for drug development, particularly as antiviral agents. We provide the first comprehensive study of their antiviral activity, in particular against SARS-CoV-2. We report the synthesis of a family of chiral indolyl-twistenediones, with the separation and characterization of both enantiomers via chiral semipreparative HPLC. The absolute configurations were determined using experimental and theoretical ECD techniques, supported by DFT calculations. A detailed biological study of their antiviral activity against various pathogenic RNA viruses demonstrates selective efficacy against members of the Coronaviridae family, specifically targeting a post-entry step in the viral replication cycle. Further investigation revealed a remarkable chiral distinction in the antiviral activity between the two enantiomers, opening new avenues for research in the 3D space of chiral cage compounds., We thank MICINN (Grant PID2023-146801NB-C32, PID2023-146801NB-C31, PID2020-113059GB-C22, PID2021-1248553NB-100), the Comunidad de Madrid (S2022/BMD-7403 RENIM-CM) co-financed by the European Structural and Investment Fund for financial support. This study was supported by Spanish National Research Council (PIE-RD-COVID-19 ref. E202020E079 and PIE_CNB_SC Ref. 202320E187 to the CNB-CSIC). This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global). We acknowledge R. Molenkamp (Erasmus University Medical Center, Rotterdam, The Netherlands; participant of the EU-funded EVA-GLOBAL project, grant agreement 871029) for the SARS-CoV-2 strain NL/2020 virus; Dr. Pei-Yong Shi (UTMB; Galveston, TX,USA) for the WNV (NY99) plasmid construct, Dr. Rodriguez (CNB-CSIC, Madrid, SPAIN) for the VSV-GFP virus, Dr. Volker Thiel (U. of Lausanne, CH) for the hCoV-229E-GFP virus and Dr. Enjuanes (CNB-CSIC, Madrid, SPAIN) for the MERS-CoV-EMC12 virus. Paula Bueno is supported by PIPF2022/SAL-GL-25488 fellowship from Comunidad de Madrid., Peer reviewed